We have also assessed the expression of other breast cancer biomarkers in our cohort (ER, HER2 and PgR and basal markers as defined by our group [19] and others [23]) and looked for the existence of correlations between the expression of the Vitamin D partners and these molecular markers (Table 3). The gene discussed is ERBB2; the disease is breast cancer.